Patheon® is a leading provider of drug substance and drug product services for the global biopharmaceutical industry. SEE AND Read More »

Meet us at 2014 AAPS Annual Conference! 
- Booth #1014 -

November 2-6 | San Diego, CA  USA

Read More

 

Oct
26

World ADC San Diego

World ADC San Diego has been designed to dramatically enhance your ADC research and development efforts. Providing access to expert intelligence on how to select your lead candidate with confidence, improve preclinical predictability and maximize clinical efficacy, the 2014 program cannot be missed.

This year, 65+ amazing speakers and over 550 of the global network of ADC developers will distil 12 months of learning into 4 jam packed days of insight and intelligence. Join us to improve your programs and be part of the mission to develop better ADC drugs.

http://adc-summit.com

Read More

Schedule a Meeting

Nov
02

2014 AAPS Annual Meeting

Plan now for the meeting that extends your boundaries.

Schedule a Meeting with Patheon!

  • Widen your personal network with scientists from all fields related to pharmaceutical sciences.
  • Explore programming including Hot Topics covering both large and small pharma.
  • Find the latest advances with more than 2,500 contributed papers.

https://www.aaps.org/annualmeeting/


Read More

Schedule a Meeting

Oct
20

BioProcess International

This year’s BioProcess International Conference & Exhibition will be held in Boston, MA. The conference is ranked the #1 BioProcessing event by the industry and the Patheon team is excited to be attending. BPI attracts experts from all bioprocessing and biomanufacturing disciplines and all levels, from research scientist to group leader to senior level executive who share and discuss their challenges in an interactive, learning environment. We hope to see you at our Booth #701!

http://www.ibclifesciences.com/BPI/overview.xml


Read More

Schedule a Meeting

Oct
29

AusBiotech 2014

AusBiotech conference is held annually to inform and update the biotechnology sector with current industry facts and knowledge.  It provides key presentations and forums to help bring together representatives and professionals from across the biotechnology industry and the globe to experience a comprehensive conference program, extensive bio-industry exhibition, business matching program and associated events such as the AusFoodtech Symposium.

http://ausbiotechnc.org

Read More

Schedule a Meeting

Nov
10

Outsourced Pharma West

Outsourced Pharma West Conference & Exhibition will engage pharmaceutical and biopharmaceutical executives who form and manage partnerships for development and manufacturing. The program includes interactive panels on drug development and partnering led by done-it-before executives, informal networking receptions, and an exhibition showcase of services providers. Presented in its inaugural year by Life Science Leader magazine, BayBio, and OutsourcedPharma.com.

http://baybio.org/outsourced-pharma-west

Read More

Schedule a Meeting

Nov
18

BIOCOM CRO Breakfast: Fast Track the Success of your Biopharmaceutical Program


Abstract: 

In the last two decades, an enormous global research effort has been directed at the development of novel biopharmaceutical products. However, translation of this new knowledge from basic science into novel therapeutics has proven challenging with small biotech companies struggling to achieve successful early stage clinical trials in a timely manner, resulting in product failures and placing the industry under considerable financial strain. Besides achieving timely proof-of-concept, the right financial structure to progress such products through the clinical development pathway is also critical to success. Although many drug candidates in development may be backed by excellent science, these products are only as strong as the regulatory, technical and commercial strategy the developer has established to see them through to the next value inflection point. Adoption of a more sophisticated and global approach to progressing biopharmaceutical programs to proof-of-concept clinical trials is needed to reduce the failure rate of these important products.

Register Here or https://biocom.org/event/index/Nov_2014_CRO_Bfast

Nov
20

Bay Bio Lunch & Learn: Faster to Phase II: High Speed & Non-Dilutive Funding for Bio Programs

Abstract: 

In this event you will hear from financial, manufacturing, bioanalytical, clinical & regulatory experts on how Australian initiatives are enabling U.S. based companies to progress their biopharmaceutical programs to Phase II faster and cheaper than anywhere else in the world, whilst maintaining the high quality standards required by global regulatory authorities. Our special guest, Tunitas Therapeutics, will speak about their experience with these initiatives and the significant value they have brought to their San-Francisco based biotech company.

• Non-dilutive financing for biopharmaceutical programs part run in Australia – up to 45% cash refund provided by the Australian Tax Office through the R&D Tax Incentive.

• Clinical trial start in as little as 4 weeks using the Australian Clinical Trial Notification scheme allowing fast track progression to global Phase II trials.

Register Here or https://baybio.org/lunch-and-learn-faster-phase-ii-11-20-2014

Feb
04

Recorded WEBCAST on Robustness, Reproducibility and Risk Management

Bringing a molecule to the market reliably and cost-effectively.

Recorded Webcast: Robustness, Reproducibility and Risk Management

For many CDMOs late stage development for solid and sterile pharmaceutical products is a critical phase and a huge challenge; manufacturing a product with reliable high quality requires a significant increase in financial commitment.

Robust, reliable and repeatable processes can pay dividends on the route to successful commercialisation and applying a Quality by Design (QbD) program can guarantee this success. Our webinar leaders will share insights into a proven path through scale up and technology transfer to commercialisation.

Speakers:

Romano Rivolta
, Senior Director Business Management and Technology Transfer, Patheon
Mike Dey, Managing Director, Claidmhor Pharma

Apr
08

Recorded WEBCAST on Challenges in the Development of Active Drug-layered Formulations

Active drug layering provides tremendous opportunities in the development of immediate-release dosage forms of a single drug entity or fixed-dose combination drugs. The technique also has been widely used to develop modified-release dosage forms as a monolithic system or as multiparticulates with a possibility of targeting the release to a specific region of the gastrointestinal tract. The development of an active drug-layered formulation can pose challenges based on properties of the API, dose, processing parameters, target release profiles required, and other factors. The webcast discusses applications of this technique, development considerations, manufacturing and analytical challenges, and case studies.

Speakers: Don Barbieri, Terri Williamson, Robert Diehl

Read More


May
23

Recorded WEBCAST on Life Cycle Management Opportunities in Softgel Technologies

Drug delivery technology based on the softgels is widely accepted as preferred dosage form in the consumer healthcare, and is recognized as an interesting life cycle opportunity for pharmaceutical products. One such opportunity is the development of dosage forms for specific populations, like pediatrics, although this area of formulation development is relatively uncovered and novel. The European Medicines Agency has stated: “The joint goal for industry, regulators, practitioners and patients is to encourage pediatric drug development in order to create a situation where substantially more children have access to safe and effective medication…”.

The webinar will present the benefits and limitations offered by Chewels™ as a pediatric dosage form through an actual case study of an approved generic application of a chewable softgel. Formulation options, manufacturing, and regulatory aspects will be discussed, with relevant subjects like pediatric guidelines, cross linking of gelatin and regulatory perception, bioequivalence approach, and general feedback on the dosage form by health authorities during the registration process.

Speakers:

Kaspar van den Dries - Senior Director Formulation Sciences Solid Dose and Softgels, Patheon

Katja van Eijndhoven - Regulatory Affairs Manager, Banner Life Sciences

Register Here

Jun
11

Recorded WEBCAST on Lyophilization Cycle Design and Scale Up

Recorded Webcast: Lyophilization Cycle Design and Scale Up – Practical Methodologies for Developing Cycles

Lyophilization or freeze drying is a well established process in manufacturing of sterile injectable products. The Lyocycle involves freezing, primary drying and secondary drying. Development of a lyo cycle and understanding of heat and mass transfer under different load conditions is critical in development of a robust lyophilization process.

The webinar will focus on establishing a lyophilization scale- up model that is aimed to demonstrate the full scalability between lab and production lyo in order to allow to perform the development or optimisation of a freeze-drying cycle in the pilot freeze dryer with significant cost savings.

Speakers:

Enrico Corona, Formulation and Production Manager, Patheon
Ronald Pate, Lyophilization Scientist, Customer Project Support, Patheon

Jun
24

Recorded WEBCAST on QbD Strategies for Successful Drug Product Formulation

Recorded WebcastQbD Strategies for Successful Drug Product Formulation

Quality-by-Design (QbD) is a strategic approach that helps companies achieve higher process understanding, enhanced control, better product quality, increased data for continuous improvement and potential for reduced FDA approval times. Implementing a robust QbD strategy allows Pharma, Biotech and contract service providers to build leaner processes and achieve the ultimate goal for successful product development and manufacturing.

This live webinar examines the opportunities in QbD projects, including the hurdles in implementing QbD from a contractors’ perspective. Join us to discover how to define a successful strategy and execute a systematic scientific plan to overcome challenges and meet regulatory requirements.

Speakers

Anil Kane Ph.D. MBA, Global Head of Formulations, Patheon
Steve Closs, Director, Global Technical Affairs, Patheon

Jul
17

Recorded WEBCAST - Analytical Challenges & Case Studies in Method Dev. for Fixed-Dose Combinations

Recorded Webcast: Analytical Challenges and Case Studies in Method Development for Fixed-Dose Combinations

Combining two or more active pharmaceutical ingredients in a single-dosage form can increase a drug’s efficacy and improve patient compliance. Pharmaceutical companies are turning to these fixed-dose combinations to maximize product value and expand a product’s lifecycle. 

In this webcast, experts will discuss challenges and solutions for the development of analytical methods associated with fixed-dose combinations. Case studies will demonstrate the complexities involved with analyzing these dosage forms. 

Speakers:

Gordon Marr, PDS Analytical Development
Maureen McLaughlin, Analytical Chemist
Yue Chen, PDS Analytical Development

Sep
17

Recorded WEBCAST on API Characterization for a Speedy and Successful Formulation Strategy

Recorded Webcast: API Characterization for a Speedy and Successful Formulation Strategy

The physicochemical properties of the API in a solid state are extremely important as they affect the choice and design of formulation as well as the performance of the dosage form. A robust solid-state characterization of the API at an early stage helps drug developers better understand the properties of the API and the effect these characteristics have on the drug behavior, especially on uniform distribution, solubility, stability, and its in-vitro dissolution and bioavailability. This information impacts formulation and development decisions. In this webinar, experts examine key API properties and their impact on formulation design and development decisions.

In this webinar, experts examine key API properties and their impact on formulation design and development decisions.

Speakers: 

Anil Kane Ph.D. MBA, Executive Director, Global Formulation Sciences, PDS
Friedrich Brandl, Quality Manager, DSM Pharma Chemicals, Regensburg (ResCom®)

Knowledge Library


Please fill the below form to access requested content

First Name

Last Name

Company

Title

Email

Phone

Address Line 1

Address Line 2

City

Zip/ Postal Code

Country

Submit

Ask a Question


*
*
*
*
*
Submit your question

Event Enrollment


First Name

Last Name

Company

Title

Email

*

Phone

Address Line 1

Address Line 2

City

State / Province

Zip/ Postal Code

Country

Submit

登録フォーム


*

*

姓 (カタカナ)

名(カタカナ)

会社名

*

郵便番号

役職

住所1

Email

* *

住所2

電話

*

送信

Apply Now


[Title,jobs]

[Location,jobs] - [Region,jobs]

First Name

Last Name

Email Address

Country

Address Line 1

Address Line 2

City

State / Province

Zip/ Postal Code

Daytime Phone

Evening Phone

Resume

Submit